A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease (Q46892910)
Jump to navigation
Jump to search
scientific article published on 12 January 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease |
scientific article published on 12 January 2006 |
Statements
1 reference
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease (English)
1 reference
1 reference
1 reference
P Papaldo
1 reference
A Fabi
1 reference
G Ferretti
1 reference
M Mottolese
1 reference
A M Cianciulli
1 reference
B Di Cocco
1 reference
M S Pino
1 reference
P Carlini
1 reference
I Sacchi
1 reference
C Nardoni
1 reference
F Cognetti
1 reference
12 January 2006
1 reference
1 reference
17
1 reference
4
1 reference
630-636
1 reference
Identifiers
1 reference
1 reference